Efficacy and safety of recently approved drugs for sickle cell disease: a review of clinical trials

Sickle cell disease is prevalent in several parts of the world. Most hospitalizations of these patients are related to pain crisis episodes. Moreover, levels of hemoglobin are lower in sickle cell disease patients as compared with the general population. Complications related to sickle cell disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Muhammad Ashar, Ahmad, Asrar, Chaudry, Hafsa, Aiman, Wajeeha, Aamir, Sobia, Anwar, Muhammad Yasir, Khan, Anam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: ISEH -- Society for Hematology and Stem Cells. Published by Elsevier Inc. 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7442900/
https://www.ncbi.nlm.nih.gov/pubmed/32841705
http://dx.doi.org/10.1016/j.exphem.2020.08.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7442900/
https://www.ncbi.nlm.nih.gov/pubmed/32841705
http://dx.doi.org/10.1016/j.exphem.2020.08.008

Ejemplares similares